A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis

PHASE3CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Myasthenia Gravis
Interventions
DRUG

Tacrolimus capsule

oral

DRUG

Placebo

oral

Trial Locations (9)

Unknown

Beijing

Guangdong

Jiangsu

Jilin

Shandong

Shanghai

Sichuan

Wuhan

Zhejiang

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma China, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT01325571 - A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis | Biotech Hunter | Biotech Hunter